Acta Med. 2015, 58: 123-127

https://doi.org/10.14712/18059694.2016.3

Dental and Oral Lesions in HIV-Positive Individuals in East Bohemia – Czech Republic, Single Centre Experience

Martin Šembera, Vladimíra Radochová, Radovan Slezák

Department of Dentistry, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Czech Republic

Received June 22, 2015
Accepted October 29, 2015

References

1. WHO. Epidemiological fact sheet on HIV/AIDS. UNAIDS 2014. (Internet). UNAIDS; available from: http://www.unaids.org/sites/default/files/en/media/unaids /contentassets/documents/factsheet/2014/20140716_FactSheet_en.pdf
2. WHO gap report epidemiology slides UNAIDS 2014 (Internet). UNAIDS; available from: http://www.unaids.org/en/media/unaids/contentassets/documents /document/2014/2014gapreportslides/01_Epi_slides_2014July.pdf
3. Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868–71. <https://doi.org/10.1126/science.6189183>
4. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984; 224: 497–500. <https://doi.org/10.1126/science.6200935>
5. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS Science 1984; 224: 500–3. <https://doi.org/10.1126/science.6200936>
6. Schüpbach J, Popovic M, Gilden RV, Gonda MA, Sarngadharan MG, Gallo RC. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science 1984; 224: 503–5. <https://doi.org/10.1126/science.6200937>
7. Sarngadharan MG, Popovic M, Bruch L, Schüpbach J, Gallo RC. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 1984; 224: 506–8. <https://doi.org/10.1126/science.6324345>
8. Hoy J. HIV Management in Australasia a guide for clinical care. Australasian Society for HIV Medicine (ASHM); 2009; 9–17.
9. SZU. Leden 2014: výskyt a šíření HIV/AIDS v České republice. (Internet); Available from: http://www.szu.cz/uploads/documents/CeM/HIV_AIDS/rocni _zpravy/2014/HIV_AIDS_01_2014.pdf
10. Interim who clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance (Internet). WHO; 2005; available from: http://www.who.int/hiv/pub /guidelines/clinicalstaging.pdf
11. Ranganathan K, Umadevi M, Saraswathi TR, Kumarasamy N, Solomon S, Johnson N. Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 South Indian patients. Ann Acad Med Singapore 2004; 33(4 Suppl): 37–42.
12. Nittayananta W, Chungpanich S. Oral lesions in a group of Thai people with AIDS. Oral Dis 1997; 3(Suppl 1): 41–5. <https://doi.org/10.1111/j.1601-0825.1997.tb00372.x>
13. Sharma G, Pai KM, Suhas S, Ramapuram JT, Doshi D, Anup N. Oral manifestations in HIV/AIDS infected patients from India. Oral Dis 2006; 12(6): 537–42. <https://doi.org/10.1111/j.1601-0825.2006.01232.x>
14. Bendick C, Scheifele C, Reichart PA. Oral manifestations in 101 Cambodians with HIV and AIDS. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 2002; 31(1): 1–4.
15. Adedigba MA, Ogunbodede EO, Jeboda SO, Naidoo S. Patterns of oral manifestation of HIV/AIDS among 225 Nigerian patients. Oral Dis 2008; 14(4): 341–6. <https://doi.org/10.1111/j.1601-0825.2007.01384.x>
16. Weinert M, Grimes RM, Lynch DP. Oral manifestations of HIV infection. Ann Intern Med 1996; 125(6): 485–96. <https://doi.org/10.7326/0003-4819-125-6-199609150-00010>
17. Sirois DA. Oral manifestations of HIV disease. Mt Sinai J Med N Y 1998; 65(5–6): 322–32.
18. Agbelusi GA, Wright AA. Oral lesions as indicators of HIV infection among routine dental patients in Lagos, Nigeria. Oral Dis 2005; 11(6): 370–3. <https://doi.org/10.1111/j.1601-0825.2005.01132.x>
19. Pinheiro A, Marcenes W, Zakrzewska JM, Robinson PG. Dental and oral lesions in HIV infected patients: a study in Brazil. Int Dent J 2004; 54(3): 131–7. <https://doi.org/10.1111/j.1875-595X.2004.tb00268.x>
20. Neville B, Damm DD, Allen, CM, Bouquot JE. Oral and Maxillofacial Pathology. 3rd edition. St. Louis: Saunders; 2009.
21. Ryder MI, Nittayananta W, Coogan M, Greenspan D, Greenspan JS. Periodontal disease in HIV/AIDS. Periodontol 2000 2012; 60(1): 78–97. <https://doi.org/10.1111/j.1600-0757.2012.00445.x>
22. Pantanowitz L, Khammissa RA, Lemmer J, Feller LJ. Oral HIV-associated Kaposi sarcoma. Oral Pathol Med. 2013; 42(3): 201–7. <https://doi.org/10.1111/j.1600-0714.2012.01180.x>
23. Arendorf TM, Bredekamp B, Cloete CA, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 1998; 27(4): 176–9.
24. Schuman P, Ohmit SE, Sobel JD, Mayer KH, Greene V, Rompalo A, et al. Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group. Am J Med 1998; 104(6): 559–64. <https://doi.org/10.1016/S0002-9343(98)00110-7>
25. Mthethwa SR, Wanjau J, Chabikuli N. The prevalence of HIV associated oral lesions among adults in the era of HAART. SADJ. 2013; 68(8): 364–71.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive